In last trading session, Windtree Therapeutics Inc (NASDAQ:WINT) saw 126.48 million shares changing hands with its beta currently measuring 0.58. Company’s recent per share price level of $1.05 trading at $0.15 or 16.67% at ring of the bell on the day assigns it a market valuation of $12.16M. That closing price of WINT’s stock is at a discount of -70131.43% from its 52-week high price of $737.43 and is indicating a premium of 65.71% from its 52-week low price of $0.36. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 25.68 million shares which gives us an average trading volume of 7.68 million if we extend that period to 3-months.
For Windtree Therapeutics Inc (WINT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
Windtree Therapeutics Inc’s shares saw a change of -99.43% in year-to-date performance and have moved 61.54% in past 5-day. Windtree Therapeutics Inc (NASDAQ:WINT) showed a performance of 75.00% in past 30-days. Number of shares sold short was 0.93 million shares which calculate 0.17 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 75.28% during past 5 years.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
Insiders are in possession of 0.01% of company’s total shares while institution are holding 1.39 percent of that, with stock having share float percentage of 1.39%. Investors also watch the number of corporate investors in a company very closely, which is 1.39% institutions for Windtree Therapeutics Inc that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 6.67 shares of worth $7002.0 or 0.18% of the total outstanding shares. The later fund manager was in possession of 2.26 shares on May 31, 2025 , making its stake of worth around $2372.0 in the company or a holder of 0.06% of company’s stock.
